trial · primary record
TGFBR2 KO CAR27/IL-15 NK cells
Pancreatic Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 37 |
| Primary completion | 2030-03-01 |
| Primary endpoint | Safety and Adverse Events (AEs) |
| Registry ID | NCT07377526 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.074Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07377526
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.